Cite
Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population.
MLA
van Riet, Nales, Diana A., et al. “Commentary on the EMA Reflection Paper on the Pharmaceutical Development of Medicines for Use in the Older Population.” British Journal of Clinical Pharmacology, vol. 88, no. 4, Apr. 2022, pp. 1500–14. EBSCOhost, https://doi.org/10.1111/bcp.15207.
APA
van Riet, N. D. A., van den Bemt, B., van Bodegom, D., Cerreta, F., Dooley, B., Eggenschwyler, D., Hirschlérova, B., Jansen, P. A. F., Karapinar, Ç. F., Moran, A., Span, J., Stegemann, S., & Sundberg, K. (2022). Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population. British Journal of Clinical Pharmacology, 88(4), 1500–1514. https://doi.org/10.1111/bcp.15207
Chicago
van Riet, Nales, Diana A., Bart van den Bemt, David van Bodegom, Francesca Cerreta, Brian Dooley, Doris Eggenschwyler, Blanka Hirschlérova, et al. 2022. “Commentary on the EMA Reflection Paper on the Pharmaceutical Development of Medicines for Use in the Older Population.” British Journal of Clinical Pharmacology 88 (4): 1500–1514. doi:10.1111/bcp.15207.